Dishman Carbogen Amcis releases Q1FY27 earnings call audio
Dishman Carbogen Amcis Limited disclosed the availability of its Q1FY27 earnings call audio recording. The call, held on August 17, 2026, reviewed financial performance for the quarter ended June 30, 2026. The recording is hosted on the company's website as per SEBI listing regulations.

*this image is generated using AI for illustrative purposes only.
Dishman Carbogen Amcis has made the audio recording of its quarterly earnings conference call available to investors. The call, which took place on Monday, August 17, 2026, focused on the company's financial results and operational performance for the quarter ended June 30, 2026.
The conference call commenced at 5:00 pm IST. In compliance with Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, the company uploaded the recording to its official website for public access.
Investors and analysts can access the audio file directly via the investor relations section of the Dishman Carbogen Amcis website. The filing was confirmed by Shrima Dave, Company Secretary, in a letter addressed to the listing departments of both the BSE and NSE.
Historical Stock Returns for Dishman Carbogen Amcis
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -7.78% | -8.92% | -9.80% | -10.56% | -34.29% | -11.44% |
How will Dishman Carbogen Amcis's Q2 2026 financial performance influence its valuation multiples relative to other generic pharmaceutical peers in the upcoming quarter?
What specific operational initiatives or cost-saving measures discussed in the call might drive margin expansion in the second half of fiscal year 2026?
Are there any indications from management regarding potential regulatory approvals or new product launches that could impact revenue growth in the next 12 months?


































